The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000419.5:c.1947-9T>C

CA2825000789

Gene: ITGA2B
Condition: Glanzmann thrombasthenia
Inheritance Mode: Autosomal recessive inheritance
UUID: 0b37294e-3193-4008-b0cc-18f8924631ae
Approved on: 2024-08-20
Published on: 2024-08-20

HGVS expressions

NM_000419.5:c.1947-9T>C
NC_000017.11:g.44378518A>G
CM000679.2:g.44378518A>G
NC_000017.10:g.42455886A>G
CM000679.1:g.42455886A>G
NC_000017.9:g.39811412A>G
NG_008331.1:g.15988T>C
ENST00000262407.6:c.1947-9T>C
ENST00000648408.1:c.1378-9T>C
ENST00000262407.5:c.1947-9T>C
ENST00000592462.5:n.742-9T>C
NM_000419.3:c.1947-9T>C
NM_000419.4:c.1947-9T>C
More

Uncertain Significance

Met criteria codes 3
PP4_Moderate PM2_Supporting BP7

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The NM_000419.5(ITGA2B):c.1947-9T>C variant is an intronic variant that is not predicted by SpliceAI to impact splicing (delta scores <0.05). In addition, it occurs at a nucleotide that is not conserved as shown by phyloP score of -0.425 (BP7). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). At least one proband (https://doi.org/10.1182/blood-2023-182694) with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia (PP4_moderate). Additionally, αIIbβ3 surface expression was absent or reduced, as measured by flow cytometry. However, ITGA2B and ITGB3 were not reported to be sequenced across all exons and intron/exon boundaries. In summary, this variant is of uncertain significance. GT-specific criteria applied: BP7, PP4_Moderate, PM2_supporting.
Met criteria codes
PP4_Moderate
At least one proband (https://doi.org/10.1182/blood-2023-182694) with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia (PP4_moderate). Additionally, αIIbβ3 surface expression was absent or reduced, as measured by flow cytometry. However, ITGA2B and ITGB3 were not reported to be sequenced across all exons and intron/exon boundaries.
PM2_Supporting
This variant is absent from gnomAD v4.1.0 (PM2_Supporting).
BP7
The NM_000419.5(ITGA2B):c.1947-9T>C variant is an intronic variant that is not predicted by SpliceAI to impact splicing (delta scores <0.05). In addition, it occurs at a nucleotide that is not conserved as shown by phyloP score of -0.425 (BP7).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.